Related content

The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?

By Ferreira Karine  

Supportive Care in Cancer, Vol. 14, Iss. 11, 2006-11 ,pp. : 1086-1093

Springer Publishing Company

Access to resources Recommend Favorite

The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC) - a critical appraisal of 20 years of continuous efforts

By Kouloulias V.E.   Poortmans P.M.   Bernier J.   Horiot J.-C.   Johansson K.-A.   Davis B.   Godson F.   Garavaglia G.   Pierart M.   van der Schueren E.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 430-437

Elsevier

Access to resources Recommend Favorite

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: A randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C)

By Andersen Jørn   Kamby Claus   Ejlertsen Bent   Cold Søren   Ewertz Marianne   Jacobsen Erik   Philip Preben   Møller Knud   Jensen Disa   Møller Susanne  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 718-724

Informa Healthcare

Access to resources Recommend Favorite

Improved survival after one course of perioperative chemotherapy in early breast cancer patients - long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854

By van der Hage J.A.   van de Velde C.J.H.   Julien J.-P.   Floiras J.-L.   Delozier T.   Vandervelden C.   Duchateau L.   cooperating investigators  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2184-2193

Elsevier

Access to resources Recommend Favorite

Breast Cancer Research and Treatment

By  

Breast Cancer Research and Treatment, Vol. 79, Iss. 2, 2003-05 ,pp. : 281-285

Springer Publishing Company

Access to resources Recommend Favorite